Correlation of Changes in Inflammatory and Collagen Biomarkers with Durable Guselkumab Efficacy Through 2 Years in Participants with Active Psoriatic Arthritis: Results from a Phase III Randomized Controlled Trial
THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE(2024)
关键词
guselkumab,IL-23/Th-17 pathway,psoriatic arthritis,serum biomarkers
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要